Marketers have more performance data than ever, yet trust in that data isn’t really improving. The fix lies in performance measurement using Marketing Mix Modeling.

Translating AI-powered research into real-world cancer impact Apotek Joins NSF I-Corps Spark Special Cohort on AI/ML and Cancer Care Taipei | [November 12, 2025] — Vizuro is proud to announce that our Apotek platform  has been selected for the National Science Foundation (NSF) I-Corps Spark Cohort , beginning November 13, 2025 . This specialized program focuses on AI/ML-powered innovations in cancer research and care , empowering teams to translate cutting-edge science into

In the highly regulated and patient-centric world of pharmaceutical launches, gaining a rapid, nuanced understanding of public perception is no longer optional—it is a critical necessity. Social listening has evolved from a simple monitoring tool into a sophisticated intelligence engine, providing real-time data that directly informs safety monitoring, brand strategy, and commercial success.

Partnership with Professor Woei-Jer Chuang of NCKU to explore AI-powered discovery in protein drug design Vizuro Apotek AI Drug Discovery Platform x Industry-Academia Collaboration with NCKU Taipei | [October 27, 2025] — Vizuro LLC, a leading innovator in multimodal causal AI and generative AI for drug discovery, today announced the signing of a Memorandum of Understanding (MOU) with Professor Woei-Jer Chuang, Ph.D., of the Department of Biochemistry and Molecular Biology, Na

AI is redefining finance, but trust remains its currency. As AI systems make increasingly high-stakes decisions—who gets a loan, who’s flagged for AML, who receives an offer—the cost of error multiplies. The message for financial leaders is clear: A black-box AI might optimize for accuracy but can expose the bank to unseen bias, regulatory penalties, or wasted budgets. A Responsible AI framework builds resilience, customer confidence, and long-term value.

Author: Chin-Lin Chen, Ph.D / Data Scientist at Vizuro Key Takeaway Drug discovery has entered the era of big data. Every year, thousands of disease and normal samples are profiled — yet one critical bottleneck remains: identifying clinically meaningful target–marker gene pairs for new drug development . The core value of Apotek Path is for this purpose: Identify disease-relevant targets → Causal modeling reveals mechanistic gene interactions tailored to your disease contex

The future of Physical AI isn't just about better technology—it's about smarter SDG implementation. Organizations that understand how to match SDG strategies with their specific Physical AI needs will gain significant competitive advantages.

Why causal AI is becoming pharma’s next strategic differentiator — from target validation to clinical trials and real-world evidence. Visualizing the Ladder of Causation in Pharma: from seeing correlations, to doing interventions, to imagining counterfactuals — the foundation of causal AI in drug discovery. Introduction: The Limits of Correlation in Drug Discovery Drug discovery today generates unprecedented volumes of data. Omics, imaging, electronic health records, and real

How Corvus's synthetic data generation platform addresses the critical challenge of matching model capabilities with data requirements...

Ad platform reports from Google, Meta, and others usually over-credit the last click and don’t reveal the true drivers of ROI....

Transforming Industrial Inspection with Corvus For industrial manufacturers, the promise of AI for quality control is undeniable....

Partnership with Professor Tsong-Long Hwang of CGUST to explore AI-powered innovations in small molecule drug design Vizuro Apotek AI Drug Discovery Platform x Industry-Academia Collaboration with CGUST Taipei | [August 22, 2025] — Vizuro LLC, a leading innovator in multimodal causal AI  and generative AI  technology, announced today that it has signed a Memorandum of Understanding (MOU) with Tsong-Long Hwang, Ph.D., Vice President and Distinguished Professor at Chang Gung U

Key Takeaways Synthetic data generation has evolved from a niche research topic to an essential technology for AI development. The...

Polus is an AI-driven solution for pharmaceutical medical affairs. It analyzes MSL (Medical Science Liaison) engagements with HCPs (Healthcare Professionals) to provide insights beyond traditional, periodic ATU (Awareness, Trial, and Usage) studies. The product uses sentiment analysis, topic analysis, and summarization to give a real-time understanding of HCP perceptions. This continuous feedback loop helps commercial and marketing teams to refine their strategies pre-launch,

We're excited to share that a recent academic paper co-authored by our Data Scientist. Ling-Yu Cai, along with a team of MD/PhD...

Why “writing problems” aren’t really about writing If you’ve ever said: “This draft doesn’t sound right.”  “It’s not what I meant.” ...

In a world flooded with writing tools, the real bottleneck isn't typing speed. It's planning structure and clarity, before the first word...

Author:  Ting-Yuan Wang, Solution Architect at Vizuro Realities of AI Implementation Over the past eight years, Vizuro has witnessed the rapid development and widespread application of AI across various industries. According to our client statistics, AI applications are most prevalent in the healthcare sector, accounting for 34%, followed by 25% in the pharmaceutical and life sciences industries, and 23% in manufacturing. Despite the enthusiasm and expectations surrounding AI

Empowering Clinicians and General Populations with Actionable Insights Diabetes is one of the world’s fastest-growing health crises,...

How CorePal uses GenAI to potentially recycle 98% of the valuable parts from junkyards to foster a circular economy With today's...